FDA gives emergency approval of Gilead’s Remdesivir to fight Covid-19

FDA gives emergency approval of Gilead’s Remdesivir to fight Covid-19

Remdesivir is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. Gilead announced that they are donating 1.5 million vials of it’s antiviral fighting drug after the FDA approved it’s use to help fight Covid-19 last week. Remdesivir showed very promising signs in fighting the effects of Covid-19 in severely ill patients.

Steve
Steve
Top in Tech
Get the App